Ohta Ryuichi, Naito Yumi, Nishikura Nozomi, Inoue Keita, Sano Chiaki
Community Care, Unnan City Hospital, Unnan, JPN.
Urology, Unnan City Hospital, Unnan, JPN.
Cureus. 2023 May 10;15(5):e38850. doi: 10.7759/cureus.38850. eCollection 2023 May.
Although cytomegalovirus (CMV) usually colonizes the human body without causing symptoms, CMV infections often develop in immunocompromised hosts. Immunosuppression can trigger CMV infection, and its prediction is essential; however, this is challenging without specific criteria. We present the case of an 87-year-old male patient who visited a rural community hospital with the chief complaint of persistent cough, productive of bloody sputum. Initially, the patient developed thrombocytopenia without any abnormalities of liver function; however, a positive myeloperoxidase antineutrophil cytoplasmic antibody (ANCA) test and the presence of alveolar hemorrhage and glomerulonephritis confirmed ANCA-associated vasculitis. The patient's symptoms and thrombocytopenia resolved transiently after treatment with prednisolone and rituximab. However, the recurrence of thrombocytopenia and the appearance of urinary intracytoplasmic inclusion bodies during the treatment course were investigated using an antigenemia test, which ultimately confirmed CMV viremia. Valganciclovir treatment resolved all the symptoms. This case report showed that thrombocytopenia might indicate the presence of CMV infection in ANCA-associated vasculitis and that intracytoplasmic inclusion bodies in immunosuppressed patients require investigation of CMV infection for effective treatment.
虽然巨细胞病毒(CMV)通常在人体定植而不引起症状,但CMV感染常在免疫功能低下的宿主中发生。免疫抑制可引发CMV感染,对其进行预测至关重要;然而,在没有特定标准的情况下,这具有挑战性。我们报告一例87岁男性患者,其因持续咳嗽、咳血痰为主诉就诊于一家农村社区医院。最初,患者出现血小板减少,肝功能无任何异常;然而,髓过氧化物酶抗中性粒细胞胞浆抗体(ANCA)检测呈阳性,且存在肺泡出血和肾小球肾炎,确诊为ANCA相关性血管炎。患者经泼尼松龙和利妥昔单抗治疗后,症状和血小板减少症短暂缓解。然而,在治疗过程中,通过抗原血症检测对血小板减少症的复发和尿内胞浆内包涵体的出现进行了调查,最终确诊为CMV病毒血症。缬更昔洛韦治疗使所有症状得以缓解。本病例报告表明,血小板减少可能提示ANCA相关性血管炎中存在CMV感染,免疫抑制患者的胞浆内包涵体需要进行CMV感染调查以实现有效治疗。